T&L Co. Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.096x

T&L Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, T&L Co. Ltd (340570) has a cash flow conversion efficiency ratio of 0.096x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩21.46 Billion ≈ $14.54 Million USD) by net assets (₩224.21 Billion ≈ $151.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of T&L Co. Ltd (2018–2025)

Cash flow conversion efficiency of T&L Co. Ltd from 2018 to 2025. This chart illustrates how T&L Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View T&L Co. Ltd (340570) stock price for real-time trading data and today's change.

T&L Co. Ltd Cash Flow Conversion Ratio Explained

T&L Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

T&L Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of T&L Co. Ltd ranked by their cash flow conversion efficiency. Also see 340570 market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Zhejiang Zhengyuan Zhihui Technology Co Ltd
SHE:300645
0.056x
MM Forgings Limited
NSE:MMFL
0.196x
AudioCodes Ltd
TA:AUDC
0.023x
Tianjin Meiteng Technology Co. Ltd. A
SHG:688420
N/A
EnviTec Biogas AG
XETRA:ETG
0.086x
NEXCOM International Co Ltd
TWO:8234
0.017x
Vogenx Inc Common Stock
NASDAQ:VOGX
-0.015x
CERRO DE PASCO RES
F:N8HP
-0.043x

Annual Cash Flow Conversion Efficiency for T&L Co. Ltd (2018–2025)

The table below shows the annual cash flow conversion efficiency of T&L Co. Ltd from 2018 to 2025. Review T&L Co. Ltd (340570) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩201.16 Billion
≈ $136.32 Million
₩37.69 Billion
≈ $25.54 Million
0.187x -31.02%
2024-12-31 ₩171.44 Billion
≈ $116.18 Million
₩46.57 Billion
≈ $31.56 Million
0.272x +7.98%
2023-12-31 ₩129.55 Billion
≈ $87.80 Million
₩32.59 Billion
≈ $22.09 Million
0.252x +73.19%
2022-12-31 ₩106.07 Billion
≈ $71.88 Million
₩15.41 Billion
≈ $10.44 Million
0.145x -31.15%
2021-12-31 ₩90.09 Billion
≈ $61.05 Million
₩19.01 Billion
≈ $12.88 Million
0.211x +62.45%
2020-12-31 ₩71.95 Billion
≈ $48.76 Million
₩9.34 Billion
≈ $6.33 Million
0.130x -44.91%
2019-12-31 ₩33.23 Billion
≈ $22.52 Million
₩7.83 Billion
≈ $5.31 Million
0.236x +0.50%
2018-12-31 ₩27.24 Billion
≈ $18.46 Million
₩6.39 Billion
≈ $4.33 Million
0.235x --

About T&L Co. Ltd

KQ:340570 Korea Medical Devices
Market Cap
$259.96 Million
₩383.60 Billion KRW
Market Cap Rank
#15248 Global
#510 in Korea
Share Price
₩24150.00
Change (1 day)
+1.68%
52-Week Range
₩23750.00 - ₩65600.00
All Time High
₩84000.00
About

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more